EXOSC3
Basic information
Region (hg38): 9:37759234-37832117
Links
Phenotypes
GenCC
Source:
- pontocerebellar hypoplasia type 1A (Definitive), mode of inheritance: AR
- pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR
- pontocerebellar hypoplasia type 1 (Supportive), mode of inheritance: AR
- pontocerebellar hypoplasia type 1B (Definitive), mode of inheritance: AR
- pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pontocerebellar hypoplasia type 1B | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 11020648; 12731647; 22544365; 24524299; 25149867 |
ClinVar
This is a list of variants' phenotypes submitted to
- Pontocerebellar hypoplasia type 1B (20 variants)
- not provided (2 variants)
- Abnormality of the nervous system (1 variants)
- Hypotonia (1 variants)
- Pontoneocerebellar hypoplasia (1 variants)
- Inborn genetic diseases (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 81 | 85 | ||||
missense | 62 | 73 | ||||
nonsense | 5 | |||||
start loss | 6 | |||||
frameshift | 13 | 18 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 6 | 7 | |||
non coding | 36 | 22 | 67 | |||
Total | 20 | 17 | 103 | 105 | 14 |
Highest pathogenic variant AF is 0.000480
Variants in EXOSC3
This is a list of pathogenic ClinVar variants found in the EXOSC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-37761968-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
9-37761975-C-T | not specified | Uncertain significance (May 23, 2023) | ||
9-37762069-G-C | not specified | Uncertain significance (Aug 30, 2021) | ||
9-37762586-C-G | not specified | Uncertain significance (Jul 05, 2022) | ||
9-37762614-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
9-37762634-A-G | not specified | Uncertain significance (Jun 22, 2021) | ||
9-37762667-A-C | not specified | Uncertain significance (Aug 17, 2021) | ||
9-37763635-G-A | not specified | Uncertain significance (May 16, 2023) | ||
9-37763715-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
9-37769942-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
9-37769958-A-C | not specified | Uncertain significance (May 26, 2024) | ||
9-37769999-T-C | not specified | Uncertain significance (May 09, 2022) | ||
9-37770710-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
9-37770723-A-T | not specified | Uncertain significance (Feb 22, 2023) | ||
9-37770724-T-G | not specified | Uncertain significance (Feb 22, 2023) | ||
9-37776285-G-T | not specified | Uncertain significance (May 26, 2024) | ||
9-37776303-C-T | not specified | Likely benign (Mar 19, 2024) | ||
9-37776373-A-C | not specified | Uncertain significance (Nov 14, 2023) | ||
9-37777616-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
9-37777622-A-T | Likely benign (Jan 01, 2023) | |||
9-37777623-C-A | Likely benign (Jan 01, 2023) | |||
9-37777666-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
9-37777687-C-T | not specified | Uncertain significance (Nov 03, 2023) | ||
9-37777691-G-A | not specified | Likely benign (Feb 06, 2023) | ||
9-37779725-C-T | Pontocerebellar hypoplasia type 1B | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXOSC3 | protein_coding | protein_coding | ENST00000327304 | 4 | 34460 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000243 | 0.777 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.224 | 162 | 154 | 1.05 | 0.00000685 | 1745 |
Missense in Polyphen | 59 | 56.303 | 1.0479 | 681 | ||
Synonymous | -2.84 | 87 | 59.2 | 1.47 | 0.00000273 | 575 |
Loss of Function | 1.08 | 7 | 10.8 | 0.646 | 5.54e-7 | 131 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000710 | 0.000681 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000928 | 0.000925 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000112 | 0.000105 |
Middle Eastern | 0.000928 | 0.000925 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5. {ECO:0000269|PubMed:11782436, ECO:0000269|PubMed:17545563, ECO:0000269|PubMed:19056938, ECO:0000269|PubMed:21255825}.;
- Disease
- DISEASE: Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]: A severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. There is diffuse muscle weakness, progressive microcephaly, global developmental delay, and brainstem involvement. {ECO:0000269|PubMed:22544365}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RNA degradation - Homo sapiens (human);Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.320
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.25
Haploinsufficiency Scores
- pHI
- 0.0805
- hipred
- Y
- hipred_score
- 0.748
- ghis
- 0.575
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.924
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Exosc3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- exosc3
- Affected structure
- motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- branchiness
Gene ontology
- Biological process
- exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U4 snRNA 3'-end processing;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;DNA deamination;isotype switching;positive regulation of isotype switching;CUT catabolic process;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription;polyadenylation-dependent snoRNA 3'-end processing
- Cellular component
- nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;transcriptionally active chromatin
- Molecular function
- 3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding